BlackRock Health Sciences Term Trust Files Proxy Statement

TL;DR

BlackRock Health Sciences Term Trust filed its proxy statement, no fee required.

AI Summary

BlackRock Health Sciences Term Trust filed a Definitive Proxy Statement (DEFA14A) on May 21, 2024. This filing is related to the company's proxy materials and does not involve a fee, as indicated by the 'No fee required' checkbox. The filing is for the fiscal year ending December 31.

Why It Matters

This filing provides shareholders with important information regarding the company's governance and voting matters, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not contain information that suggests immediate or significant financial risk.

Key Players & Entities

• BlackRock Health Sciences Term Trust (company) — Registrant
• DEFA14A (document) — Filing Type
• May 21, 2024 (date) — Filing Date
• 100 BELLEVUE PARKWAY, WILMINGTON, DE 19809 (address) — Business Address

FAQ

Filing Documents

• d842420ddefa14a.htm (DEFA14A) — 8KB
• g842420g01g01.jpg (GRAPHIC) — 277KB
• 0001193125-24-143129.txt ( ) — 390KB

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Your vote matters BlackRock Health Sciences Term Trust (NYSE: BMEZ) Dear Shareholder, We are reaching out to notify you of an important announcement that benefits you as a shareholder. On May 20, 2024, BlackRock Health Sciences Term Trust (NYSE: BMEZ) announced a distribution rate increase to 12% of net asset value, payable monthly (+99% relative to the prior distribution rate). We have taken this step to support shareholders of these Funds, consistent with our goal of delivering long-term value. We are focused on enhancing returns for our closed-end fund shareholders and helping them plan for their financial futures, said R. Glenn Hubbard, Chair of the Board of BlackRock Closed-End Funds. Defend YOUR Fund, Save YOUR Income At BMEZs upcoming annual meeting on June 25, activist hedge fund Saba Capital Management (Saba) is putting your dependable, income-paying investment in jeopardy by attempting to install its own hand-picked Board nominees and fire BlackRock, the largest closed-end fund manager, as manager of the Fund. If Saba prevails, your Fundand the consistent monthly income you rely on will be at risk. BlackRock is fighting for YOU. Vote today on the enclosed WHITE proxy card: FOR the BlackRock Board nominees AGAINST Sabas proposal to terminate the Funds investment management agreement with BlackRock Visit www.blackrock.com/defend to learn more © 2024 BlackRock, Inc. or its affiliates. All Rights Reserved. BLACKROCK is a trademark of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners.

View Full Filing

View this DEFA14A filing on SEC EDGAR